Magnetic resonance elastography (MRE) has been introduced for clinical evaluation of liver fibrosis for nearly a decade. MRE has proven to be a robust and accurate technique for diagnosis and staging of liver fibrosis. As clinical experience with MRE grows, the possible role in evaluation of other diffuse and focal disorders of liver is emerging. Stiffness maps provide an opportunity to evaluate mechanical properties within a large volume of liver tissue. This enables appreciation of spatial heterogeneity of stiffness. Stiffness maps may reveal characteristic and differentiating features of chronic liver diseases and focal liver lesions and therefore provide useful information for clinical management. The objective of this pictorial review is to recapture the essentials of MRE technique and illustrate with examples, the utility of stiffness maps in other chronic liver disorders and focal liver lesions.
Magnetic resonance elastography (MRE) has been used for clinical evaluation of liver fibrosis for nearly a decade since its first clinical application in 2007 [1] . MRE has proven to be an accurate, reproducible, and reliable noninvasive technique for detection and staging of liver fibrosis caused by many different chronic liver diseases [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . The worldwide experience with this new technique is growing and the technique has been applied for both initial evaluation and treatment response assessment for a spectrum of chronic liver diseases [12] [13] [14] . There is also growing interest in the use of MRE for characterizing focal liver lesions and assessing their response to therapy [15] [16] [17] [18] .
MRE, unlike other elastography techniques provides a stiffness map (elastogram) that displays stiffnesses of tissues in large areas across the abdomen. This provides an opportunity for the assessment of stiffness distribution not only within the liver but also other abdominal organs. The volume of liver parenchyma assessed with a single slice of MRE is about 250 cm 3 which is much higher with shear wave elastography (20 cm 3 ), point shear wave elastography (0.5-1.0 cm 3 ), transient elastography (4 cm 3 ) , and nearly 500 times that of a liver biopsy (10-50 mm 3 or < 0.05 cm 3 ) [19] [20] [21] . Assessing a large volume of liver provides an opportunity to appreciate the stiffness distribution within the liver parenchyma. The pattern of stiffness across the liver may provide clues for diagnosis of a specific diffuse disease or point towards a focal pathology. Knowledge of liver pathology that can cause diffuse or focal increased stiffness is important for interpretation of the clinical MRE. In this pictorial review, we demonstrate with examples, the different causes of increased liver stiffness, Correspondence to: Sudhakar K. Venkatesh; email: Venkatesh.Sud hakar@mayo.edu variability in the stiffness distribution, characteristic patterns of stiffness in chronic liver disease, and also causes for focal increased or decreased stiffness.
Magnetic resonance elastography (MRE) and generation of stiffness maps
The basic principle of MRE is to image the propagation of shear waves within the tissue. Shear waves are created by mechanically applied low frequency continuous vibrations. The propagating shear waves are detected and mathematically processed into quantitative images depicting tissue stiffness, known as stiffness maps or elastograms. MRE has three important steps (Fig. 1) . The first step is to generate shear waves in the liver. This is achieved by conducting low frequency (60 Hz) vibrations produced by an active pneumatic mechanical wave driver placed outside the magnet room. The active driver is connected by a long plastic tube to a passive driver that is placed in contact with lower chest wall/anterior abdominal wall overlying the right lobe of the liver. The passive driver has a soft vibrating membrane in contact with anterior abdominal wall that produces shear waves, which propagate through the entire abdomen including the liver. The propagating shear waves cause tissue displacement typically in the order of microns. The second step is to image the pattern of tissue displacements with a motion-encoded phase-contrast MRE sequence. The pulse sequence uses trigger pulses to synchronize the motion-encoding gradients with the applied vibrations. By imaging the propagating waves at regular intervals in each wave cycle, snapshots of the propagating waves are obtained. The MRE sequence produces two kinds of images-the magnitude image showing the cross-sectional anatomy and the phase image containing motion information. The third step is to process the wave images to generate a quantitative map of tissue stiffness, known Steps in MRE of liver and generation of stiffness map. Top image showing the typical location of the passive driver on a T2W image in a patient with chronic hepatitis C cirrhosis. Magnitude and Phase maps (second row) are displayed on the scanner within seconds of acquiring an MRE slice. The color wave map, stiffness maps in gray scale, color map, and confidence maps (bottom row) are processed on the scanner and displayed within few minutes after completion of MRE sequence. The arrow shows the color scale from 0 to 8 kPa provided on the color map. Arrowheads point to the hashed out regions that are outside confidence limits. In this particular example, nearly the entire cross section of the liver is within confidence map. , and confidence map (C) in a 57-year-old female with BMI of 33.6 kg/m 2 and non-alcoholic steatohepatitis. The ROI includes entire liver and mean stiffness is 7.2 kPa. Middle row showing magnitude (D), stiffness map (E), and confidence map (F) in a 56-year-old female with BMI of 42.8 kg/m 2 with alcoholic cirrhosis. Arrow points to the artifact due to cholecystectomy clips which is seen as an area of low stiffness and the confidence map hashes out that region. The geographical ROI covers most of the right lobe of the liver and mean stiffness was 6.8 kPa. Bottom row showing wave image (G), stiffness map (H), and confidence map (I) in a 58-year-old female with BMI of 38.4 kg/m 2 and fatty liver. Note that the confidence map hashes out most of the liver except for small peripheral region in right lobe which shows wave propagation (arrow, G). The ROI is drawn within the confidence map and is much smaller than two examples above. Mean stiffness was 1.8 kPa. Smaller regions of confidence may be seen in normal livers as healthy non-fibrotic liver parenchyma is soft and absorbs shear wave energy causing rapid attenuation of waves deep in the liver. This should not be interpreted as failed MRE study.
as stiffness map or elastogram. The processing takes place automatically after the scan is completed. For detailed description of MRE technique please see previous reviews on the technique [1, 22, 23] .
The most commonly used clinical MRE sequence is two-dimensional gradient echo sequences (2D-GRE MRE). Other sequences are modified spin-echo (SE) and spin-echo echo-planar imaging (EPI) MRE. 2D-GRE MRE is not limited by obesity but loss of signal caused by the short T2* transverse relaxation time of iron overloaded liver may cause low signal-to-noise ratio (SNR) of the liver parenchyma. The low SNR results in poor visualization of the propagating shear waves. In such cases SE and SE-EPI MRE may be useful for obtaining better tissue signal [24] .
Stiffness map (elastogram)
In 2D MRE, an elastogram is a two-dimensional image representing the stiffnesses of the tissues in a cross-sectional slice of the anatomy, typically with thickness of 5-10 mm. This quantitative map displays the mechanical property known as the magnitude of complex shear modulus which is measured in units of kilopascals (kPa). Detailed explanation of different mechanical properties of tissues used in evaluation of liver fibrosis can be found elsewhere [25, 26] . The stiffness maps can be either gray scale or color-coded (rainbow) maps with a scale (Fig. 1) provided for interpretation. Red and purple colors represent the higher and lower ends of the stiffness scale, respectively. Different vendors display slightly different hues of color in the color stiffness maps to maintain distinctions; however, all of them provide a color scale map of 0-8 kPa that is standardized across all vendors. Slight variation in the smoothness of the maps may be seen as the matrix size and/or resolution has changed and improved inversion algorithms have become available over the years.
Liver stiffness is measured by drawing regions of interest (ROI) either on gray scale map or color-coded map depending on the platform used (Fig. 2) . A confidence map (Fig. 1) is a complex statistical signal-to-noise measure that is derived from a regional least squares fit of the phase difference wave data and it excludes noisy or discontinuous data. A checkerboard overlay is placed on the elastogram to depict regions of lowest confidence or less reliable measurement. ROIs should be drawn largely within the region of highest confidence. The ROI is drawn following the liver contour, avoiding the liver edge to exclude partial volume effects. Larger (geographical) ROIs are preferred (less sampling error). Left lobe measurements may be affected by cardiac pulsations and therefore are preferably not included in the ROIs whenever possible. The ROIs should exclude large vessels (> 3 mm), hot spots (a focal region of artefactual high stiffness) typically found immediately below the passive driver, regions of wave interference, and liver fissures and gallbladder fossa (Fig. 3 ). Mean stiffness from each ROI is obtained. For typical clinical use, when reporting estimates of liver fibrosis, the average stiffness (± SD) from ROIs from four slices through the largest cross section of liver is calculated. Due to spatial heterogeneity of liver stiffness, a qualitative description of the distribution of fibrosis is often added to the report.
Liver stiffness
The normal (healthy, non-fibrotic) liver parenchyma stiffness should be less than 2.5 kPa [27] . Normal liver stiffness is dependent on: (a) tissue components including hepatocytes, bile ducts, interstitial space, intercellular matrix, and capsule; (b) tissue organization which is a Fig. 3 . Examples illustrating areas to avoid when drawing regions of interest. Top row showing an area of hot spot (dotted circle) in stiffness map (A) that corresponds to area of large wave amplitude on wave image (B) . No focal lesions demonstrated on corresponding T2W image (C). Hot spots are usually seen under the passive driver. Second row shows area of low stiffness (D, arrow) that corresponds to a region separating two wave fronts (E) and fissure for ligamentum teres seen on magnitude image (F). Third row showing region of low stiffness in the region of gallbladder fossa (arrow, G), corresponding to an area of low amplitude waves (arrow, H) and hypointensity due to gallstones in corresponding anatomical image (I). Fourth row showing a focal region of increased stiffness (white circle, J) due to wave interference (white circle, K) with no corresponding anatomical abnormality on magnitude image (L). Fifth row demonstrating a focal area of decreased stiffness (white arrow, M) secondary to artifact, and wave interference (white arrow, N) with no corresponding focal abnormality on magnitude image (O). Changing the position of passive driver may help in removing the wave interference artifacts. Arrow heads (E, H) point to vascular pulsation artifacts. c regular pattern of cords and lobules in liver; (c) vascular component comprised sinusoids, blood flow, and blood pressure. Interstitial pressure is typically low (0-2 mmHg) in normal liver parenchyma [28] . Liver is also wrapped by a thin capsule (Glisson's) that also contributes to the stiffness measured. Any external factor that compresses or puts strain on the liver can increase liver stiffness.
Pathological conditions that result in alterations in the tissue components, organizational structure of parenchyma, vascular components, and interstitial pressure would lead to altered liver stiffness.
Diffuse increased liver stiffness

Liver fibrosis
Chronic liver disease resulting in fibrosis and cirrhosis is the most common cause of significantly elevated liver stiffness and is of high clinical significance. Chronic liver diseases are characterized by hepatocyte loss, an increase in extracellular collagen content (liver fibrosis/cirrhosis), and disruption of lobules and nodule formation. The architectural disruption is accompanied by reduced portal venous flow and a compensatory increased arterial flow. Intrahepatic vascular shunts are also commonly present in advanced fibrosis and cirrhosis. The vascular changes lead to portal hypertension. Extracellular collagen deposition in liver fibrosis is the most significant contributing factor for diffuse liver stiffness. The collagen deposition typically occurs in small increments in early stages of fibrosis and becomes exponential in advanced stages of fibrosis [29] [30] [31] . Liver stiffness shows a similar trend of mild increase in stiffness in early stages and exponential increase in stiffness in advanced stages [3, 7, 8, 32] .
Spatial heterogeneity of stiffness distribution in liver fibrosis
Liver parenchyma stiffness in chronic liver disease is not uniform with some regions showing more stiffness than other regions. This phenomenon is well known and likely reflects heterogeneous collagen deposition throughout the liver [33] . In fact, spatial heterogeneity is one of the major limitations of liver biopsy and ultrasound-based elastography techniques which sample a small volume of liver parenchyma, and therefore may not accurately reflect the overall burden of fibrosis. Heterogeneity of fibrosis deposition becomes prominent in advanced fibrosis and cirrhosis [34] [35] [36] . Stiffness maps correspondingly show more heterogeneity as the fibrosis stage advances. Stiffness maps can also be used to perform imaging guided biopsy in order to target the most diseased regions of the liver and to reduce sampling error.
Stiffness distribution may vary between patients even though biopsy determined fibrosis stage is the same (Fig. 4) . The distribution of stiffness may also vary between etiologies (Fig. 5) . There is very little data on fibrosis distribution versus etiology. Different cutoffs are used for staging liver fibrosis from different etiologies with ultrasound-based elastography techniques [37] . However, with MRE the data are still emerging and it is possible that different cutoffs may be established in the future, specifically for NAFLD [38] .
As experience with clinical use of MRE grows, there is definite potential to find features that are characteristic of a chronic liver disease. In our experience we have observed that in primary sclerosing cholangitis (Figs. 6,  7) , increased stiffness may be found in the periphery of the liver particularly in early stages. As the disease advances, a segmental or lobar distribution of increased stiffness may progress in the advanced stage to involve the entire liver. When the entire liver is involved, the elastogram appearance of PSC may be indistinguishable from other diffuse liver diseases. Multifocal biliary strictures and peripheral increased liver stiffness may be diagnostic of primary sclerosing cholangitis.
MRE may demonstrate increased liver stiffness due to fibrosis even when there are no morphological signs of fibrosis or cirrhosis (Fig. 8) . It is useful to perform MRE in patients who are clinically suspected to have liver fibrosis but conventional imaging does not show any morphological characteristics (Fig. 9 ).
Inflammation
Acute inflammatory processes such as acute infective hepatitis, acute autoimmune hepatitis and acute flare of chronic liver disease can cause diffusely increased liver stiffness. This increased stiffness is probably due to recruitment of inflammatory cells and associated edema and hyperemia in the inflamed liver which causes parenchymal expansion and stretching of the liver capsule. The increased liver stiffness may be severe sometimes simulating cirrhosis (Fig. 10) . Often in clinical Fig. 10 . Acute inflammation. A 66-year-old male with no prior history of liver disease presented with jaundice and fatigue with elevated serum ALT of 1773 (Normal, < 55 IU/L), AST 1244 (Normal, < 48 IU/L). MRI and MRE were performed. Axial T2W image (A) and intravenous gadolinium enhanced portal venous phase (B) do not reveal any significant abnormality in liver. MRE (C) shows significantly elevated mean liver stiffness of 8.6 kPa. Biopsy showed severe inflammatory infiltrate, marked interface activity, severe lobular inflammatory with several necroinflammatory foci with focal bridging necrosis. Periportal fibrosis (stage 2) was also present. Findings were consistent with autoimmune hepatitis and patient responded to oral steroids and azathioprine therapy and currently on follow-up. Fig. 11 . A 56-year-old female with history of alcoholism. At initial presentation showing elevated liver stiffness measuring 14 kPa (A). After abstinence and follow-up at 7 months shows liver stiffness returning to nearly normal (2.6 kPa) (B).
follow-ups, there may be an acute increase in liver stiffness due to flare. This is commonly seen in chronic hepatitis C and autoimmune hepatitis; correlation with laboratory findings is useful for confirmation. Staging of liver fibrosis should be avoided during acute inflammation. Follow-up MRE for liver fibrosis staging can be performed when acute inflammation has subsided (typically 3-6 months) or when laboratory tests particularly serum alanine aminotransferase (ALT), a marker of liver inflammation returns to normal. Other causes of acute inflammation include acute alcoholic hepatitis (Fig. 11 ) and follow-up MRE can be useful to show reduced stiffness to near normal levels in patients who show abstinence.
Chronic inflammation or subacute inflammation that frequently accompanies fibrosis in chronic liver diseases such as viral hepatitis, steatohepatitis, and autoimmune hepatitis can case a mild increase in stiffness (typically raising liver stiffness to no more than 3 kPa) [2] . The contribution of chronic inflammation to overall liver stiffness is difficult to quantify and separate from fibrosis with current MRE technique and inversion. Advances in MRE technique may help in the future to separate the contributions of inflammation and fibrosis to overall liver stiffness [39] . Chronic inflammation and liver fibrosis is probably best viewed as a continuum in the progression of disease as inflammation results in liver fibrosis if untreated.
Biliary obstruction
Biliary obstruction especially occurring in the central hilar region can lead to diffuse increased liver stiffness (Fig. 12) . This is likely due to increased interstitial pressure secondary to biliary obstruction and cholestasis. More peripheral biliary obstruction may result in lobar, segmental, or sub-segmental pattern of increased stiffness and can be observed in primary sclerosing cholangitis.
Passive congestion
Passive venous congestion of the liver due to obstruction in the hepatic venous outflow, congestive heart failure, congenital heart diseases with pulmonary stenosis, and tricuspid regurgitation can lead to congestive hepatopathy. This causes sinusoidal congestion that can lead to increased liver stiffness. Clinical history of congenital heart disease, imaging findings of dilated inferior vena cava and hepatic veins (Fig. 13) should provide the clue to the diagnosis. Congestive hepatopathy also leads to peripheral increased liver stiffness particularly in the right lobe (Fig. 25) which bears the most brunt of passive venous congestion [40] . Chronic congestive hepatopathy can lead to liver fibrosis and cirrhosis [41] and hepatic fibrosis can be difficult to differentiate from congestive hepatopathy alone with MRE (Fig. 13) . Advances in MRE in the future may be able to quantify stiffness resulting from congestion alone and distinguish from other causes such as fibrosis and inflammation. 
Diffuse infiltrative disorders
Diffuse infiltrative processes can also lead to increased liver stiffness. The infiltrative pathologies by themselves cause increased stiffness or can also lead to liver fibrosis which in turn will increase liver stiffness. Sarcoidosis is a systemic inflammatory disorder characterized by chronic inflammation with non-caseating granulomas. Patients with involvement of liver with sarcoidosis may be asymptomatic and detected incidentally (Fig. 14) . Sarcoidosis can lead to scarring of the liver and ultimately to fibrosis simulating a cirrhotic liver (Fig. 15) . History of sarcoidosis and no other chronic liver disease may help in arriving at correct diagnosis. Lymphoma can also cause diffuse increase in liver stiffness (Fig. 16 ) without any signs of fibrosis or cirrhosis. Presence of lymphadenopathy elsewhere is an important clue to differentiate from liver fibrosis alone. Amyloidosis is a systemic disorder resulting in the deposition of gamma chains in multiple organs including the liver. Amyloid deposition in the liver causes extremely elevated liver stiffness (Fig. 17) , probably the stiffest diffuse livers one would come across in clinical practice.
Liver metastases may diffusely infiltrate the entire liver. MRE may show diffusely elevated liver stiffness (Fig. 18 ) similar to cirrhosis and should be differentiated. MRI features of primary or other metastatic lesions and clinical history would be useful in distinction.
In summary, elevated liver stiffness may result from several different pathologies. Correlation with clinical features, liver function tests, and imaging findings are important when interpreting elevated liver stiffness.
Focal or segmental increased stiffness
Stiffness maps may reveal focal regions of increased stiffness within a normal liver parenchyma or within diffusely stiff liver secondary to fibrosis. These are often localized to few segments or may correspond to focal liver lesions. Examples include confluent fibrosis (Fig. 19) , focal biliary stricture (Fig. 20) , healing infective/inflammatory process by fibrosis (Fig. 21) , and focal liver lesions (Figs. 22, 23) . Malignant focal liver lesions may be recognized as region of increased stiffness in a normal or mildly stiff liver parenchyma, but may not be distinguishable from surrounding liver if the parenchyma is fibrotic and therefore also abnormally stiff (Fig. 22) .
Focal or segmental decreased stiffness in a diffusely stiff liver
Regions of decreased stiffness within abnormal liver parenchyma may be seen and they usually correspond to a region of normal or regenerating liver parenchyma. Regenerative nodules have similar or slightly higher stiffness than normal liver parenchyma and may appear as focal regions of decreased stiffness in a cirrhotic liver ( Fig. 24) , often surrounded by a rim of increased stiffness representing fibrosis (Fig. 25) .
A focal lesion that has same stiffness as surrounding liver parenchyma may not be detectable on stiffness maps. Some benign lesions such as hemangiomas and hepatic adenomas may have similar stiffness as surrounding liver parenchyma and not detectable (stealth lesions) (Fig. 26) on stiffness maps. Currently, the stiffness maps are of low resolution (96 9 96 to 128 9 256) and therefore small focal lesions are not easily resolved.
Also with 2D MRE, the entire liver is typically not assessed and therefore stiffness maps should not be used alone for detection of focal liver lesions. However, if new 3D MRE techniques are being used, nearly entire liver can be covered [38, 42, 43] .
Liver tumors that undergo necrosis following locoregional treatment may demonstrate decreased stiffness when they undergo internal necrosis (Fig. 27 ). This finding may be useful for demonstrating response to treatment [18] . 
Summary/conclusion
MRE is well-established for identifying hepatic fibrosis and cirrhosis in chronic liver disease. Inflammation, congestion, biliary obstruction, and diffuse infiltrative diseases can also lead to increased liver stiffness.
Peripheral distribution of elevated stiffness is often present in early PSC and passive hepatic congestion which may be useful for early detection. Regions of abnormal stiffness may have corresponding findings on conventional MRI sequences and the information may be complementary for detecting pathology. 
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